<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>OBJECTIVE: To study trough levels of <z:chebi fb="0" ids="6801">metformin</z:chebi> in serum and its intra-individual variation in patients using a newly developed assay </plain></SENT>
<SENT sid="1" pm="."><plain>RESEARCH DESIGN AND METHODS: Trough serum levels of <z:chebi fb="0" ids="6801">metformin</z:chebi> were measured once using liquid chromatography-tandem mass spectrometry (LCMSMS) in 137 type 2 diabetic patients with varying renal function (99 men) and followed repeatedly during 2 months in 20 patients (16 men) with estimated glomerular filtration rate (eGFR) &lt;60 ml/min/1.73 m(2) body surface </plain></SENT>
<SENT sid="2" pm="."><plain>RESULTS: Patients with eGFR &gt;60, 30-60, and &lt;30 ml/min/1.73 m(2) had median trough <z:chebi fb="0" ids="6801">metformin</z:chebi> concentrations of 4.5 micromol/l (range 0.1-20.7, n = 107), 7.71 micromol/l (0.12-15.15, n = 21), and 8.88 micromol/l (5.99-18.60, n = 9), respectively </plain></SENT>
<SENT sid="3" pm="."><plain>The median intra-individual overall coefficient of variation was 29.4% (range 9.8-74.2) </plain></SENT>
<SENT sid="4" pm="."><plain>CONCLUSIONS: Determination of serum <z:chebi fb="0" ids="6801">metformin</z:chebi> with the LCMSMS technique is useful in patients on <z:chebi fb="0" ids="6801">metformin</z:chebi> treatment </plain></SENT>
<SENT sid="5" pm="."><plain>Few patients had values &gt;20 micromol/l </plain></SENT>
<SENT sid="6" pm="."><plain><z:chebi fb="0" ids="6801">Metformin</z:chebi> measurement is less suitable for dose titration </plain></SENT>
</text></document>